Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) Associated with Moderately Emetogenic (MEC) Chemotherapy in Patients with Breast Cancer

被引：0
|
作者：
Webb, T.
Hardwick, J.
Carides, A. D.
Street, J. C.
机构：
[1] Genesis Canc Ctr, Hot Springs, AR USA
[2] Merck Res Labs, Upper Gwynedd, PA USA
[3] Reagent, New York, NY USA
来源：
CANCER RESEARCH | 2009年 / 69卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：575S / 576S
页数：2
相关论文
共 50 条
  • [1] Aprepitant (APR) for the prevention of chemotherapy-induced nausea and vomiting (CINV) associated with moderately emetogenic chemotherapy (MEC) in breast and non-breast cancers
    Gralla, R.
    Rapoport, B.
    Brown, C.
    Street, J. C.
    Hardwick, J. S.
    Carides, A. D.
    [J]. EJC SUPPLEMENTS, 2009, 7 (03): : 23 - 24
  • [2] Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic (MEC) or highly emetogenic (HEC) chemotherapies in patients with lung cancer
    Rapoport, B.
    Boice, J. A.
    Brown, C.
    Street, J. C.
    Hardwick, J. S.
    Carides, A. D.
    Gralla, R. J.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 519 - 520
  • [3] Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy
    Warr, DG
    Hesketh, PJ
    Gralla, RJ
    Muss, HB
    Herrstedt, J
    Eisenberg, PD
    Raftopoulos, H
    Grunberg, SM
    Gabriel, M
    Rodgers, A
    Bohidar, N
    Klinger, G
    Hustad, CM
    Horgan, KJ
    Skobieranda, F
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) : 2822 - 2830
  • [4] Analysis of aprepitant for prevention of chemotherapy-induced nausea and vomiting with moderately and highly emetogenic chemotherapy
    Molassiotis, Alex
    Nguyen, Allison Martin
    Rittenberg, Cynthia N.
    Makalinao, Alex
    Carides, Alexandra
    [J]. FUTURE ONCOLOGY, 2013, 9 (10) : 1443 - 1450
  • [5] Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) in moderately emetogenic therapy (MEC)
    Hesketh, Paul Joseph
    Schwartzberg, Lee Steven
    Modiano, Manuel R.
    Arora, Sujata
    Poma, Allen
    Schnadig, Ian D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] APREPITANT IN THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING ASSOCIATED WITH MODERATELY OR HIGHLY EMETOGENIC CHEMOTHERAPIES IN PATIENTS WITH GASTROINTESTINAL CANCER
    Boice, J.
    Brown, C.
    Taylor, A.
    Hardwick, J.
    Carides, A.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 : 69 - 69
  • [7] The efficacy of aprepitant in salvage treatment of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy for patients with gastrointestinal cancer
    Qiaoyan Gong
    Jiangfang Tian
    Yulian Jiang
    Xiaofen Li
    Lingyan Zhou
    Dan Cao
    [J]. International Journal of Clinical Oncology, 2021, 26 : 1091 - 1098
  • [8] The efficacy of aprepitant in salvage treatment of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy for patients with gastrointestinal cancer
    Gong, Qiaoyan
    Tian, Jiangfang
    Jiang, Yulian
    Li, Xiaofen
    Zhou, Lingyan
    Cao, Dan
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (06) : 1091 - 1098
  • [9] Aprepitant for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy
    Takako Inoue
    Madoka Kimura
    Junji Uchida
    Kazumi Nishino
    Toru Kumagai
    Junko Taniguchi
    Fumio Imamura
    [J]. International Journal of Clinical Oncology, 2017, 22 : 600 - 604
  • [10] Aprepitant for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy
    Inoue, Takako
    Kimura, Madoka
    Uchida, Junji
    Nishino, Kazumi
    Kumagai, Toru
    Taniguchi, Junko
    Imamura, Fumio
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (03) : 600 - 604
12345